{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:02:02Z","timestamp":1759010522000},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T00:00:00Z","timestamp":1312416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s11882-011-0212-9","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T18:46:27Z","timestamp":1312397187000},"page":"369-377","source":"Crossref","is-referenced-by-count":25,"title":["Recent Insights into the Pathobiology of Innate Immune Deficiencies"],"prefix":"10.1007","volume":"11","author":[{"given":"Sergio D.","family":"Rosenzweig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,4]]},"reference":[{"issue":"5418","key":"212_CR1","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.284.5418.1313","volume":"284","author":"JA Hoffmann","year":"1999","unstructured":"Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science. 1999;284(5418):1313\u20138. Review.","journal-title":"Science"},{"issue":"5566","key":"212_CR2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.1068883","volume":"296","author":"R Medzhitov","year":"2002","unstructured":"Medzhitov R, Janeway Jr CA. Decoding the patterns of self and nonself by the innate immune system. Science. 2002;296(5566):298\u2013300.","journal-title":"Science"},{"issue":"5963","key":"212_CR3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","volume":"327","author":"A Iwasaki","year":"2010","unstructured":"\u2022 Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327(5963):291\u20135. Review. The authors in this review discuss the mechanisms by which pathogen-specific innate immune recognition activates antigen-specific adaptive immune responses, and the roles of different types of innate immune recognition in host defense against infection and injury.","journal-title":"Science"},{"key":"212_CR4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","volume":"15","author":"E Bach","year":"1997","unstructured":"Bach E, Aguet M, Schriber R. The IFNgamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol. 1997;15:563\u201391.","journal-title":"Annu Rev Immunol"},{"key":"212_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","volume":"20","author":"JL Casanova","year":"2002","unstructured":"Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581\u2013620.","journal-title":"Annu Rev Immunol"},{"key":"212_CR6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.0105-2896.2005.00227.x","volume":"203","author":"SD Rosenzweig","year":"2005","unstructured":"Rosenzweig SD, Holland SM. Defects in the interferon-g and interleukin-12 pathways. Immunol Rev. 2005;203:38\u201347.","journal-title":"Immunol Rev"},{"key":"212_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.2008.00698.x","volume":"226","author":"S-Y Zhang","year":"2008","unstructured":"Zhang S-Y, Boisson-Dupuis S, Chapgier A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-a\/b, IFN-g, and IFN-l in host defense. Immunol Rev. 2008;226:29\u201340.","journal-title":"Immunol Rev"},{"issue":"9451","key":"212_CR8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","volume":"364","author":"SE Dorman","year":"2004","unstructured":"Dorman SE, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon-gamma receptor 1 deficiencies. Lancet. 2004;364(9451):2113\u201321.","journal-title":"Lancet"},{"key":"212_CR9","unstructured":"\u2022\u2022 de Beaucoudrey, Bustamante J, Cobat A, et al. Revisiting human IL-12Rb1 deficiency: a survey of 140 patients from 30 countries. Medicine 2011, in press. The largest series of patients with the most common form of mendelian susceptibility to mycobacterial diseases is presented in this paper. Besides the well-known increased infectious susceptibility to mycobacteria and salmonella and partial penetrance of the disease, more than 25% of the analyzed patients also presented with recurrent Candida spp infections, mostly thrush."},{"issue":"6","key":"212_CR10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaci.2008.08.018","volume":"122","author":"EP Hanson","year":"2008","unstructured":"\u2022\u2022 Hanson EP, Monaco-Shawver L, Solt LA, et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122(6):1169\u20131177.e16. In this work, 72 patients with NEMO hypomorphic mutations were analyzed. A wide spectrum of clinical manifestations were shown, and a genotype\u2013phenotype correlation for NEMO hypomorphic changes was suggested.","journal-title":"J Allergy Clin Immunol"},{"issue":"7157","key":"212_CR11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157):1058\u201362. Epub 2007 Aug 5.","journal-title":"Nature"},{"issue":"1","key":"212_CR12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.180.1.647","volume":"180","author":"A Puel","year":"2008","unstructured":"\u2022 Puel A, Picard C, Lorrot M, et al. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol. 2008;180(1):647\u201354. A patient with recurrent staphylococcal infections and no increase in C-reactive protein during those infections is described in this paper. The patient presented with high titers of neutralizing anti\u2013IL-6 antibodies that could explain both his infectious disease susceptibility and his lack of acute-phase reactant response.","journal-title":"J Immunol"},{"issue":"6","key":"212_CR13","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1172\/JCI37083","volume":"119","author":"A Chapgier","year":"2009","unstructured":"Chapgier A, Kong XF, Boisson-Dupuis S, Jouanguy E, Averbuch D, Feinberg J, et al. A partial form of recessive STAT1 deficiency in humans. J Clin Invest. 2009;119(6):1502\u20131.","journal-title":"J Clin Invest"},{"issue":"5","key":"212_CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/08830180902995645","volume":"28","author":"N Rezaei","year":"2009","unstructured":"\u2022 Rezaei N, Moazzami K, Aghamohammadi A, et al. Neutropenia and primary immunodeficiency diseases. Int Rev Immunol. 2009;28(5):335\u201366. In this review, the authors revise all PIDs in which neutropenia is described.","journal-title":"Int Rev Immunol"},{"issue":"1","key":"212_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOH.0b013e32831ac557","volume":"16","author":"T Kawai","year":"2009","unstructured":"Kawai T, Malech HL. WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol. 2009;16(1):20\u20136. Review.","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"212_CR16","first-page":"1074","volume":"118","author":"K Balabanian","year":"2008","unstructured":"\u2022 Balabanian K, Levoye A, Klemm L, et al. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J Clin Invest. 2008;118(3):1074\u201384. Authors in this paper identified GRK3 as a negative regulator of CXCL12-induced chemotaxis (CXCL12, natural ligand for CXCR4) and as a candidate for CXCR4 dysfunction in patients with WHIM syndrome and no mutations in CXCR4.","journal-title":"J Clin Invest"},{"key":"212_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-0-387-72005-0_5","volume":"601","author":"A Etzioni","year":"2007","unstructured":"Etzioni A. Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options. Adv Exp Med Biol. 2007;601:51\u201360.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"212_CR18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1182\/blood-2007-04-082552","volume":"111","author":"G Uzel","year":"2008","unstructured":"\u2022 Uzel G, Tng E, Rosenzweig SD, et al. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood. 2008;111(1):209\u201318. Three LAD1 patients with somatic reversions on CD18 are shown in this paper. The biological effects of these reversions are also explored. Interestingly, the reverted cells were predominantly cytotoxic T cells with a memory\/effector phenotype and may have altered immune regulation properties favoring gastrointestinal inflammatory manifestations.","journal-title":"Blood"},{"key":"212_CR19","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1182\/blood.V86.4.1629.bloodjournal8641629","volume":"86","author":"C Thomas","year":"1995","unstructured":"Thomas C, Le Deist F, Cavazzana-Calvo M, et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood. 1995;86:1629\u201335.","journal-title":"Blood"},{"issue":"1","key":"212_CR20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm1695","volume":"14","author":"TR Bauer Jr","year":"2008","unstructured":"Bauer Jr TR, Allen JM, Hai M, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med. 2008;14(1):93\u20137.","journal-title":"Nat Med."},{"issue":"5","key":"212_CR21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/gt.2010.7","volume":"17","author":"EJ Nelson","year":"2010","unstructured":"Nelson EJ, Tuschong LM, Hunter MJ, et al. Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency. Gene Ther. 2010;17(5):672\u20137.","journal-title":"Gene Ther"},{"issue":"2","key":"212_CR22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-009-9354-0","volume":"30","author":"Y Gazit","year":"2010","unstructured":"Gazit Y, Mory A, Etzioni A, et al. Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature. J Clin Immunol. 2010;30(2):308\u20131.","journal-title":"J Clin Immunol"},{"issue":"11","key":"212_CR23","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2009-04-218636","volume":"114","author":"E Manevich-Mendelson","year":"2009","unstructured":"Manevich-Mendelson E, Feigelson SW, Pasvolsky R, et al. Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions. Blood. 2009;114(11):2344\u201353.","journal-title":"Blood"},{"key":"212_CR24","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1073\/pnas.080074897","volume":"97","author":"DR Ambruso","year":"2000","unstructured":"Ambruso DR, Knall C, Abell AN, et al. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci USA. 2000;97:4654\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"212_CR25","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/jama.2009.1806","volume":"302","author":"JM Routes","year":"2009","unstructured":"\u2022\u2022 Routes JM, Grossman WJ, Verbsky J, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA. 2009;302(22):2465\u201370. Results of the newborn screening program for severe combined immunodeficiency\/severe T-cell lymphopenia in Wisconsin are shown in this study. This group quantitated TCR excision circles from dried blood spots collected on neonatal blood\u2013screening Guthrie cards.","journal-title":"JAMA"},{"key":"212_CR26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","volume":"79","author":"BH Segal","year":"2000","unstructured":"Segal BH, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170.","journal-title":"Medicine (Baltimore)"},{"issue":"27","key":"212_CR27","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"DB Kuhns","year":"2010","unstructured":"\u2022\u2022 Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. 2010;363(27):2600\u201310. A genotype\u2013phenotype correlation and the clinical impact of residual ROI generation in CGD patients are presented in this paper.","journal-title":"N Engl J Med"},{"issue":"15","key":"212_CR28","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1182\/blood-2009-07-231498","volume":"114","author":"JD Matute","year":"2009","unstructured":"\u2022 Matute JD, Arias AA, Wright NA, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114(15):3309\u201315. A new form of recessive CGD is described in this paper.","journal-title":"Blood"},{"issue":"Suppl 1","key":"212_CR29","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s10875-007-9160-5","volume":"28","author":"SD Rosenzweig","year":"2008","unstructured":"Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28 Suppl 1:S67\u201372.","journal-title":"J Clin Immunol"},{"key":"212_CR30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.clim.2008.09.013","volume":"130","author":"J Roesler","year":"2009","unstructured":"Roesler J. Carriers of X-linked chronic granulomatous disease at risk. Clin Immunol. 2009;130:233.","journal-title":"Clin Immunol"},{"issue":"7175","key":"212_CR31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature06471","volume":"451","author":"L Romani","year":"2008","unstructured":"Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature. 2008;451(7175):211\u20135.","journal-title":"Nature"},{"key":"212_CR32","doi-asserted-by":"crossref","unstructured":"De Ravin SS, Zarember KA, Long-Priel D, et al. Tryptophan\/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease. Blood. 2010 May 28.","DOI":"10.1182\/blood-2009-07-233734"},{"issue":"2","key":"212_CR33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaci.2007.10.037","volume":"121","author":"D Hartl","year":"2008","unstructured":"Hartl D, Lehmann N, Hoffmann F, et al. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. J Allergy Clin Immunol. 2008;121(2):375\u201338.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"212_CR34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clim.2008.06.005","volume":"129","author":"KL Brown","year":"2008","unstructured":"Brown KL, Bylund J, MacDonald KL, et al. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol. 2008;129(1):90\u201310.","journal-title":"Clin Immunol"},{"issue":"10","key":"212_CR35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/embor.2009.203","volume":"10","author":"MA Cooper","year":"2009","unstructured":"Cooper MA, Colonna M, Yokoyama WM. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep. 2009;10(10):1103\u201310.","journal-title":"EMBO Rep"},{"issue":"8","key":"212_CR36","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/eji.200939435","volume":"39","author":"JC Sun","year":"2009","unstructured":"Sun JC, Lanier LL. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol. 2009;39(8):2059\u201364.","journal-title":"Eur J Immunol"},{"issue":"6","key":"212_CR37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ACI.0b013e3280106b65","volume":"6","author":"JS Orange","year":"2006","unstructured":"Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol. 2006;6(6):399\u2013409.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"12","key":"212_CR38","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1002\/eji.200939800","volume":"39","author":"J Diana","year":"2009","unstructured":"\u2022 Diana J, Lehuen A. NKT cells: friend or foe during viral infections? Eur J Immunol. 2009;39(12):3283\u201391. In this review, the authors explain the role of NKT cells during different viral infections and their interactions with other immune cells.","journal-title":"Eur J Immunol"},{"issue":"3","key":"212_CR39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI44182","volume":"121","author":"HY Kim","year":"2011","unstructured":"\u2022\u2022 Kim HY, Eyheramonho MB, Pichavant M, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest. 2011;121(3):1111\u20138. HAV-triggered fulminant hepatic failure is the leading cause of pediatric acute liver failure in developing countries. In this article, the authors describe a genetic susceptibility factor (polymorphism 157insMTTTVP in TIM1\/HAVcr1) to be associated with this condition, and propose a new pathophysiologic mechanism in which iNKT cells (liver lymphocyte residents) carrying this particular polymorphism are responsible for the early liver damage after HAV infection.","journal-title":"J Clin Invest"},{"issue":"5","key":"212_CR40","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI37901","volume":"119","author":"K Huck","year":"2009","unstructured":"\u2022\u2022 Huck K, Feyen O, Niehues T, et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest. 2009;119(5):1350\u20138. The authors of this paper describe a novel immunodeficiency syndrome in which recessive mutations in ITK lead to a fatal inadequate immune response to EBV resembling X-linked lymphoproliferative syndromes. Deficiency of IL-2\u2013inducible T-cell kinase, the product of ITK, is associated with quantitative and functional T- and NKT-cell defects in humans and murine models.","journal-title":"J Clin Invest"},{"issue":"4","key":"212_CR41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.20081773","volume":"206","author":"M Locci","year":"2009","unstructured":"\u2022 Locci M, Draghici E, Marangoni F, et al. The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J Exp Med. 2009;206(4):735\u201342. Researchers in this paper found a profound reduction in circulating iNKT cells in WAS patients that correlated directly with the severity of clinical phenotype. They also found a maturation arrest on iNKT cell in was(\u2212\/\u2212)-deficient mice, as well as a functional impairment in these cells.","journal-title":"J Exp Med"},{"key":"212_CR42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.59.060106.185110","volume":"59","author":"D Kavanagh","year":"2008","unstructured":"Kavanagh D, Richards A, Atkinson J. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med. 2008;59:293\u2013309.","journal-title":"Annu Rev Med"},{"issue":"3","key":"212_CR43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2008.07324.x","volume":"143","author":"CJ Fang","year":"2008","unstructured":"Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol. 2008;143(3):336\u201348.","journal-title":"Br J Haematol"},{"issue":"24","key":"212_CR44","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","volume":"115","author":"I Isnardi","year":"2010","unstructured":"\u2022 Isnardi I, Ng YS, Menard L, et al. Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115(24):5026\u201336. This paper shows that some patients with rheumatoid arthritis, as well as a subgroup of patients with common variable immunodeficiency, display an increased frequency of CD21-negative (or low) B cells in their blood. These cells express germline autoreactive antibodies, are unable to become activated, and are also anergic.","journal-title":"Blood"},{"issue":"34","key":"212_CR45","doi-asserted-by":"crossref","first-page":"14490","DOI":"10.1073\/pnas.0903477106","volume":"106","author":"RA Barrington","year":"2009","unstructured":"\u2022 Barrington RA, Schneider TJ, Pitcher LA, et al. Uncoupling CD21 and CD19 of the B-cell coreceptor. Proc Natl Acad Sci USA. 2009;106(34):14490\u20135. Findings in this study confirm the importance of interaction of complement receptor CD21 and CD19 for co-receptor activity in humoral immunity but identify a role for CD21 in B-cell memory independent of CD19: uncoupling of CD21 and CD19 significantly diminishes survival of germinal center B cells and secondary antibody titers.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"212_CR46","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","volume":"106","author":"M Rakhmanov","year":"2009","unstructured":"\u2022 Rakhmanov M, Keller B, Gutenberger S, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci USA. 2009;106(32):13451\u20136. This study reveals that in common variable immunodeficiency, CD21 low B cells are a distinct, polyclonal, preactivated, partially autoreactive, functionally attenuated B-cell population with preferential enrichment in peripheral tissues.","journal-title":"Proc Natl Acad Sci USA"},{"key":"212_CR47","doi-asserted-by":"crossref","unstructured":"Browne SK, Holland SM. Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms. Lancet Infectious Diseases 2011, in press.","DOI":"10.1016\/S1473-3099(10)70196-1"},{"issue":"2","key":"212_CR48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ecl.2009.01.011","volume":"38","author":"N Shikama","year":"2009","unstructured":"Shikama N, Nusspaumer G, Holl\u00e4nder GA. Clearing the AIRE: on the pathophysiological basis of the autoimmune polyendocrinopathy syndrome type-1. Endocrinol Metab Clin North Am. 2009;38(2):273\u201388.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"212_CR49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","volume":"207","author":"A Puel","year":"2010","unstructured":"\u2022\u2022 Puel A, D\u00f6ffinger R, Natividad A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207(2):291\u20137. The authors of this paper show that the presence of anti\u2013IL-17A, IL-17F, and IL-22 neutralizing antibodies are associated with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type 1 but absent in controls, as well as in more than 100 patients with other autoimmune diseases.","journal-title":"J Exp Med"},{"issue":"2","key":"212_CR50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","volume":"207","author":"K Kisand","year":"2010","unstructured":"\u2022\u2022 Kisand K, B\u00f8e Wolff AS, Podkrajsek KT, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207(2):299\u2013308. The investigators in this paper show the presence of neutralizing anti\u2013IL-17F and IL-22 antibodies in more than 150 patients with chronic mucocutaneous candidiasis and AIRE mutations, and establish their pathophysiologic role underlying chronic mucocutaneous candidiasis manifestations in these patients.","journal-title":"J Exp Med"},{"key":"212_CR51","unstructured":"\u2022\u2022 Puel A, Cypowyj S, Bustamante J, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011 Feb 24 [Epub ahead of print]. Two kindreds, one carrying homozygous nonsense mutations in IL17RA (Q284X) and another carrying heterozygous missense mutations in IL17F (S65L), presented with recurrent and severe Candida spp infections, reinforcing the critical role of IL-17 in mucocutaneous Candida infection control. Interestingly, IL17F-dominant mutations appear to be not fully penetrant, although not less severe."}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-011-0212-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-011-0212-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-011-0212-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:13:32Z","timestamp":1592784812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-011-0212-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,4]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1007\/s11882-011-0212-9","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,4]]}}}